Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Olmesartan API Market Growth 2022-2028

  • LP 4877523
  • 127 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Olmesartan API will have significant change from previous year. According to our (LP Information) latest study, the global Olmesartan API market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Olmesartan API market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Olmesartan API market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Olmesartan API market, reaching US$ million by the year 2028. As for the Europe Olmesartan API landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Olmesartan API players cover Coba Pharma, Acura Labs, Interquim, and Euro API, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Olmesartan API market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Purity 99%

Purity > 99%

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Tablet Products

Capsule Products

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Coba Pharma

Acura Labs

Interquim

Euro API

Biophore India Pharmaceuticals

Jai Radhe

Summit Pharmaceuticals Europe

Octavius Pharma Pvt. Ltd

Zeon Health lndustries

Sanofi

Glenmark Pharmaceuticals Europe

Verdant Pharma

Hubei Yitai Pharmaceuticals

Ulkar Kimya

Zhejiang Tianyu Pharmaceutical

Teva API

Zhejiang Huahai Pharmaceutical

Venkata Narayana Active Ingredients

Cadila Pharmaceuticals

Unimark Remedies

Vasudha Pharma

Macleods Pharmaceuticals

Mylan

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Olmesartan API Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Olmesartan API by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Olmesartan API by Country/Region, 2017, 2022 & 2028

2.2 Olmesartan API Segment by Type

2.2.1 Purity 99%

2.2.2 Purity > 99%

2.3 Olmesartan API Sales by Type

2.3.1 Global Olmesartan API Sales Market Share by Type (2017-2022)

2.3.2 Global Olmesartan API Revenue and Market Share by Type (2017-2022)

2.3.3 Global Olmesartan API Sale Price by Type (2017-2022)

2.4 Olmesartan API Segment by Application

2.4.1 Tablet Products

2.4.2 Capsule Products

2.4.3 Others

2.5 Olmesartan API Sales by Application

2.5.1 Global Olmesartan API Sale Market Share by Application (2017-2022)

2.5.2 Global Olmesartan API Revenue and Market Share by Application (2017-2022)

2.5.3 Global Olmesartan API Sale Price by Application (2017-2022)

3 Global Olmesartan API by Company

3.1 Global Olmesartan API Breakdown Data by Company

3.1.1 Global Olmesartan API Annual Sales by Company (2020-2022)

3.1.2 Global Olmesartan API Sales Market Share by Company (2020-2022)

3.2 Global Olmesartan API Annual Revenue by Company (2020-2022)

3.2.1 Global Olmesartan API Revenue by Company (2020-2022)

3.2.2 Global Olmesartan API Revenue Market Share by Company (2020-2022)

3.3 Global Olmesartan API Sale Price by Company

3.4 Key Manufacturers Olmesartan API Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Olmesartan API Product Location Distribution

3.4.2 Players Olmesartan API Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Olmesartan API by Geographic Region

4.1 World Historic Olmesartan API Market Size by Geographic Region (2017-2022)

4.1.1 Global Olmesartan API Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Olmesartan API Annual Revenue by Geographic Region

4.2 World Historic Olmesartan API Market Size by Country/Region (2017-2022)

4.2.1 Global Olmesartan API Annual Sales by Country/Region (2017-2022)

4.2.2 Global Olmesartan API Annual Revenue by Country/Region

4.3 Americas Olmesartan API Sales Growth

4.4 APAC Olmesartan API Sales Growth

4.5 Europe Olmesartan API Sales Growth

4.6 Middle East & Africa Olmesartan API Sales Growth

5 Americas

5.1 Americas Olmesartan API Sales by Country

5.1.1 Americas Olmesartan API Sales by Country (2017-2022)

5.1.2 Americas Olmesartan API Revenue by Country (2017-2022)

5.2 Americas Olmesartan API Sales by Type

5.3 Americas Olmesartan API Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Olmesartan API Sales by Region

6.1.1 APAC Olmesartan API Sales by Region (2017-2022)

6.1.2 APAC Olmesartan API Revenue by Region (2017-2022)

6.2 APAC Olmesartan API Sales by Type

6.3 APAC Olmesartan API Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Olmesartan API by Country

7.1.1 Europe Olmesartan API Sales by Country (2017-2022)

7.1.2 Europe Olmesartan API Revenue by Country (2017-2022)

7.2 Europe Olmesartan API Sales by Type

7.3 Europe Olmesartan API Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Olmesartan API by Country

8.1.1 Middle East & Africa Olmesartan API Sales by Country (2017-2022)

8.1.2 Middle East & Africa Olmesartan API Revenue by Country (2017-2022)

8.2 Middle East & Africa Olmesartan API Sales by Type

8.3 Middle East & Africa Olmesartan API Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Olmesartan API

10.3 Manufacturing Process Analysis of Olmesartan API

10.4 Industry Chain Structure of Olmesartan API

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Olmesartan API Distributors

11.3 Olmesartan API Customer

12 World Forecast Review for Olmesartan API by Geographic Region

12.1 Global Olmesartan API Market Size Forecast by Region

12.1.1 Global Olmesartan API Forecast by Region (2023-2028)

12.1.2 Global Olmesartan API Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Olmesartan API Forecast by Type

12.7 Global Olmesartan API Forecast by Application

13 Key Players Analysis

13.1 Coba Pharma

13.1.1 Coba Pharma Company Information

13.1.2 Coba Pharma Olmesartan API Product Offered

13.1.3 Coba Pharma Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Coba Pharma Main Business Overview

13.1.5 Coba Pharma Latest Developments

13.2 Acura Labs

13.2.1 Acura Labs Company Information

13.2.2 Acura Labs Olmesartan API Product Offered

13.2.3 Acura Labs Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Acura Labs Main Business Overview

13.2.5 Acura Labs Latest Developments

13.3 Interquim

13.3.1 Interquim Company Information

13.3.2 Interquim Olmesartan API Product Offered

13.3.3 Interquim Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Interquim Main Business Overview

13.3.5 Interquim Latest Developments

13.4 Euro API

13.4.1 Euro API Company Information

13.4.2 Euro API Olmesartan API Product Offered

13.4.3 Euro API Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Euro API Main Business Overview

13.4.5 Euro API Latest Developments

13.5 Biophore India Pharmaceuticals

13.5.1 Biophore India Pharmaceuticals Company Information

13.5.2 Biophore India Pharmaceuticals Olmesartan API Product Offered

13.5.3 Biophore India Pharmaceuticals Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Biophore India Pharmaceuticals Main Business Overview

13.5.5 Biophore India Pharmaceuticals Latest Developments

13.6 Jai Radhe

13.6.1 Jai Radhe Company Information

13.6.2 Jai Radhe Olmesartan API Product Offered

13.6.3 Jai Radhe Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Jai Radhe Main Business Overview

13.6.5 Jai Radhe Latest Developments

13.7 Summit Pharmaceuticals Europe

13.7.1 Summit Pharmaceuticals Europe Company Information

13.7.2 Summit Pharmaceuticals Europe Olmesartan API Product Offered

13.7.3 Summit Pharmaceuticals Europe Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Summit Pharmaceuticals Europe Main Business Overview

13.7.5 Summit Pharmaceuticals Europe Latest Developments

13.8 Octavius Pharma Pvt. Ltd

13.8.1 Octavius Pharma Pvt. Ltd Company Information

13.8.2 Octavius Pharma Pvt. Ltd Olmesartan API Product Offered

13.8.3 Octavius Pharma Pvt. Ltd Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Octavius Pharma Pvt. Ltd Main Business Overview

13.8.5 Octavius Pharma Pvt. Ltd Latest Developments

13.9 Zeon Health lndustries

13.9.1 Zeon Health lndustries Company Information

13.9.2 Zeon Health lndustries Olmesartan API Product Offered

13.9.3 Zeon Health lndustries Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Zeon Health lndustries Main Business Overview

13.9.5 Zeon Health lndustries Latest Developments

13.10 Sanofi

13.10.1 Sanofi Company Information

13.10.2 Sanofi Olmesartan API Product Offered

13.10.3 Sanofi Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Sanofi Main Business Overview

13.10.5 Sanofi Latest Developments

13.11 Glenmark Pharmaceuticals Europe

13.11.1 Glenmark Pharmaceuticals Europe Company Information

13.11.2 Glenmark Pharmaceuticals Europe Olmesartan API Product Offered

13.11.3 Glenmark Pharmaceuticals Europe Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Glenmark Pharmaceuticals Europe Main Business Overview

13.11.5 Glenmark Pharmaceuticals Europe Latest Developments

13.12 Verdant Pharma

13.12.1 Verdant Pharma Company Information

13.12.2 Verdant Pharma Olmesartan API Product Offered

13.12.3 Verdant Pharma Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Verdant Pharma Main Business Overview

13.12.5 Verdant Pharma Latest Developments

13.13 Hubei Yitai Pharmaceuticals

13.13.1 Hubei Yitai Pharmaceuticals Company Information

13.13.2 Hubei Yitai Pharmaceuticals Olmesartan API Product Offered

13.13.3 Hubei Yitai Pharmaceuticals Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Hubei Yitai Pharmaceuticals Main Business Overview

13.13.5 Hubei Yitai Pharmaceuticals Latest Developments

13.14 Ulkar Kimya

13.14.1 Ulkar Kimya Company Information

13.14.2 Ulkar Kimya Olmesartan API Product Offered

13.14.3 Ulkar Kimya Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Ulkar Kimya Main Business Overview

13.14.5 Ulkar Kimya Latest Developments

13.15 Zhejiang Tianyu Pharmaceutical

13.15.1 Zhejiang Tianyu Pharmaceutical Company Information

13.15.2 Zhejiang Tianyu Pharmaceutical Olmesartan API Product Offered

13.15.3 Zhejiang Tianyu Pharmaceutical Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Zhejiang Tianyu Pharmaceutical Main Business Overview

13.15.5 Zhejiang Tianyu Pharmaceutical Latest Developments

13.16 Teva API

13.16.1 Teva API Company Information

13.16.2 Teva API Olmesartan API Product Offered

13.16.3 Teva API Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Teva API Main Business Overview

13.16.5 Teva API Latest Developments

13.17 Zhejiang Huahai Pharmaceutical

13.17.1 Zhejiang Huahai Pharmaceutical Company Information

13.17.2 Zhejiang Huahai Pharmaceutical Olmesartan API Product Offered

13.17.3 Zhejiang Huahai Pharmaceutical Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Zhejiang Huahai Pharmaceutical Main Business Overview

13.17.5 Zhejiang Huahai Pharmaceutical Latest Developments

13.18 Venkata Narayana Active Ingredients

13.18.1 Venkata Narayana Active Ingredients Company Information

13.18.2 Venkata Narayana Active Ingredients Olmesartan API Product Offered

13.18.3 Venkata Narayana Active Ingredients Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Venkata Narayana Active Ingredients Main Business Overview

13.18.5 Venkata Narayana Active Ingredients Latest Developments

13.19 Cadila Pharmaceuticals

13.19.1 Cadila Pharmaceuticals Company Information

13.19.2 Cadila Pharmaceuticals Olmesartan API Product Offered

13.19.3 Cadila Pharmaceuticals Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Cadila Pharmaceuticals Main Business Overview

13.19.5 Cadila Pharmaceuticals Latest Developments

13.20 Unimark Remedies

13.20.1 Unimark Remedies Company Information

13.20.2 Unimark Remedies Olmesartan API Product Offered

13.20.3 Unimark Remedies Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Unimark Remedies Main Business Overview

13.20.5 Unimark Remedies Latest Developments

13.21 Vasudha Pharma

13.21.1 Vasudha Pharma Company Information

13.21.2 Vasudha Pharma Olmesartan API Product Offered

13.21.3 Vasudha Pharma Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Vasudha Pharma Main Business Overview

13.21.5 Vasudha Pharma Latest Developments

13.22 Macleods Pharmaceuticals

13.22.1 Macleods Pharmaceuticals Company Information

13.22.2 Macleods Pharmaceuticals Olmesartan API Product Offered

13.22.3 Macleods Pharmaceuticals Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 Macleods Pharmaceuticals Main Business Overview

13.22.5 Macleods Pharmaceuticals Latest Developments

13.23 Mylan

13.23.1 Mylan Company Information

13.23.2 Mylan Olmesartan API Product Offered

13.23.3 Mylan Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)

13.23.4 Mylan Main Business Overview

13.23.5 Mylan Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Olmesartan API Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Olmesartan API Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Purity 99%

Table 4. Major Players of Purity > 99%

Table 5. Global Olmesartan API Sales by Type (2017-2022) & (Tons)

Table 6. Global Olmesartan API Sales Market Share by Type (2017-2022)

Table 7. Global Olmesartan API Revenue by Type (2017-2022) & ($ million)

Table 8. Global Olmesartan API Revenue Market Share by Type (2017-2022)

Table 9. Global Olmesartan API Sale Price by Type (2017-2022) & (US$/Kg)

Table 10. Global Olmesartan API Sales by Application (2017-2022) & (Tons)

Table 11. Global Olmesartan API Sales Market Share by Application (2017-2022)

Table 12. Global Olmesartan API Revenue by Application (2017-2022)

Table 13. Global Olmesartan API Revenue Market Share by Application (2017-2022)

Table 14. Global Olmesartan API Sale Price by Application (2017-2022) & (US$/Kg)

Table 15. Global Olmesartan API Sales by Company (2020-2022) & (Tons)

Table 16. Global Olmesartan API Sales Market Share by Company (2020-2022)

Table 17. Global Olmesartan API Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Olmesartan API Revenue Market Share by Company (2020-2022)

Table 19. Global Olmesartan API Sale Price by Company (2020-2022) & (US$/Kg)

Table 20. Key Manufacturers Olmesartan API Producing Area Distribution and Sales Area

Table 21. Players Olmesartan API Products Offered

Table 22. Olmesartan API Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Olmesartan API Sales by Geographic Region (2017-2022) & (Tons)

Table 26. Global Olmesartan API Sales Market Share Geographic Region (2017-2022)

Table 27. Global Olmesartan API Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Olmesartan API Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Olmesartan API Sales by Country/Region (2017-2022) & (Tons)

Table 30. Global Olmesartan API Sales Market Share by Country/Region (2017-2022)

Table 31. Global Olmesartan API Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Olmesartan API Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Olmesartan API Sales by Country (2017-2022) & (Tons)

Table 34. Americas Olmesartan API Sales Market Share by Country (2017-2022)

Table 35. Americas Olmesartan API Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Olmesartan API Revenue Market Share by Country (2017-2022)

Table 37. Americas Olmesartan API Sales by Type (2017-2022) & (Tons)

Table 38. Americas Olmesartan API Sales Market Share by Type (2017-2022)

Table 39. Americas Olmesartan API Sales by Application (2017-2022) & (Tons)

Table 40. Americas Olmesartan API Sales Market Share by Application (2017-2022)

Table 41. APAC Olmesartan API Sales by Region (2017-2022) & (Tons)

Table 42. APAC Olmesartan API Sales Market Share by Region (2017-2022)

Table 43. APAC Olmesartan API Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Olmesartan API Revenue Market Share by Region (2017-2022)

Table 45. APAC Olmesartan API Sales by Type (2017-2022) & (Tons)

Table 46. APAC Olmesartan API Sales Market Share by Type (2017-2022)

Table 47. APAC Olmesartan API Sales by Application (2017-2022) & (Tons)

Table 48. APAC Olmesartan API Sales Market Share by Application (2017-2022)

Table 49. Europe Olmesartan API Sales by Country (2017-2022) & (Tons)

Table 50. Europe Olmesartan API Sales Market Share by Country (2017-2022)

Table 51. Europe Olmesartan API Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Olmesartan API Revenue Market Share by Country (2017-2022)

Table 53. Europe Olmesartan API Sales by Type (2017-2022) & (Tons)

Table 54. Europe Olmesartan API Sales Market Share by Type (2017-2022)

Table 55. Europe Olmesartan API Sales by Application (2017-2022) & (Tons)

Table 56. Europe Olmesartan API Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Olmesartan API Sales by Country (2017-2022) & (Tons)

Table 58. Middle East & Africa Olmesartan API Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Olmesartan API Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Olmesartan API Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Olmesartan API Sales by Type (2017-2022) & (Tons)

Table 62. Middle East & Africa Olmesartan API Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Olmesartan API Sales by Application (2017-2022) & (Tons)

Table 64. Middle East & Africa Olmesartan API Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Olmesartan API

Table 66. Key Market Challenges & Risks of Olmesartan API

Table 67. Key Industry Trends of Olmesartan API

Table 68. Olmesartan API Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Olmesartan API Distributors List

Table 71. Olmesartan API Customer List

Table 72. Global Olmesartan API Sales Forecast by Region (2023-2028) & (Tons)

Table 73. Global Olmesartan API Sales Market Forecast by Region

Table 74. Global Olmesartan API Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Olmesartan API Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Olmesartan API Sales Forecast by Country (2023-2028) & (Tons)

Table 77. Americas Olmesartan API Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Olmesartan API Sales Forecast by Region (2023-2028) & (Tons)

Table 79. APAC Olmesartan API Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Olmesartan API Sales Forecast by Country (2023-2028) & (Tons)

Table 81. Europe Olmesartan API Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Olmesartan API Sales Forecast by Country (2023-2028) & (Tons)

Table 83. Middle East & Africa Olmesartan API Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Olmesartan API Sales Forecast by Type (2023-2028) & (Tons)

Table 85. Global Olmesartan API Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Olmesartan API Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Olmesartan API Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Olmesartan API Sales Forecast by Application (2023-2028) & (Tons)

Table 89. Global Olmesartan API Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Olmesartan API Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Olmesartan API Revenue Market Share Forecast by Application (2023-2028)

Table 92. Coba Pharma Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors

Table 93. Coba Pharma Olmesartan API Product Offered

Table 94. Coba Pharma Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 95. Coba Pharma Main Business

Table 96. Coba Pharma Latest Developments

Table 97. Acura Labs Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors

Table 98. Acura Labs Olmesartan API Product Offered

Table 99. Acura Labs Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 100. Acura Labs Main Business

Table 101. Acura Labs Latest Developments

Table 102. Interquim Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors

Table 103. Interquim Olmesartan API Product Offered

Table 104. Interquim Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 105. Interquim Main Business

Table 106. Interquim Latest Developments

Table 107. Euro API Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors

Table 108. Euro API Olmesartan API Product Offered

Table 109. Euro API Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 110. Euro API Main Business

Table 111. Euro API Latest Developments

Table 112. Biophore India Pharmaceuticals Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors

Table 113. Biophore India Pharmaceuticals Olmesartan API Product Offered

Table 114. Biophore India Pharmaceuticals Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 115. Biophore India Pharmaceuticals Main Business

Table 116. Biophore India Pharmaceuticals Latest Developments

Table 117. Jai Radhe Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors

Table 118. Jai Radhe Olmesartan API Product Offered

Table 119. Jai Radhe Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 120. Jai Radhe Main Business

Table 121. Jai Radhe Latest Developments

Table 122. Summit Pharmaceuticals Europe Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors

Table 123. Summit Pharmaceuticals Europe Olmesartan API Product Offered

Table 124. Summit Pharmaceuticals Europe Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 125. Summit Pharmaceuticals Europe Main Business

Table 126. Summit Pharmaceuticals Europe Latest Developments

Table 127. Octavius Pharma Pvt. Ltd Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors

Table 128. Octavius Pharma Pvt. Ltd Olmesartan API Product Offered

Table 129. Octavius Pharma Pvt. Ltd Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 130. Octavius Pharma Pvt. Ltd Main Business

Table 131. Octavius Pharma Pvt. Ltd Latest Developments

Table 132. Zeon Health lndustries Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors

Table 133. Zeon Health lndustries Olmesartan API Product Offered

Table 134. Zeon Health lndustries Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 135. Zeon Health lndustries Main Business

Table 136. Zeon Health lndustries Latest Developments

Table 137. Sanofi Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors

Table 138. Sanofi Olmesartan API Product Offered

Table 139. Sanofi Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 140. Sanofi Main Business

Table 141. Sanofi Latest Developments

Table 142. Glenmark Pharmaceuticals Europe Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors

Table 143. Glenmark Pharmaceuticals Europe Olmesartan API Product Offered

Table 144. Glenmark Pharmaceuticals Europe Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 145. Glenmark Pharmaceuticals Europe Main Business

Table 146. Glenmark Pharmaceuticals Europe Latest Developments

Table 147. Verdant Pharma Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors

Table 148. Verdant Pharma Olmesartan API Product Offered

Table 149. Verdant Pharma Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 150. Verdant Pharma Main Business

Table 151. Verdant Pharma Latest Developments

Table 152. Hubei Yitai Pharmaceuticals Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors

Table 153. Hubei Yitai Pharmaceuticals Olmesartan API Product Offered

Table 154. Hubei Yitai Pharmaceuticals Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 155. Hubei Yitai Pharmaceuticals Main Business

Table 156. Hubei Yitai Pharmaceuticals Latest Developments

Table 157. Ulkar Kimya Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors

Table 158. Ulkar Kimya Olmesartan API Product Offered

Table 159. Ulkar Kimya Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 160. Ulkar Kimya Main Business

Table 161. Ulkar Kimya Latest Developments

Table 162. Zhejiang Tianyu Pharmaceutical Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors

Table 163. Zhejiang Tianyu Pharmaceutical Olmesartan API Product Offered

Table 164. Zhejiang Tianyu Pharmaceutical Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 165. Zhejiang Tianyu Pharmaceutical Main Business

Table 166. Zhejiang Tianyu Pharmaceutical Latest Developments

Table 167. Teva API Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors

Table 168. Teva API Olmesartan API Product Offered

Table 169. Teva API Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 170. Teva API Main Business

Table 171. Teva API Latest Developments

Table 172. Zhejiang Huahai Pharmaceutical Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors

Table 173. Zhejiang Huahai Pharmaceutical Olmesartan API Product Offered

Table 174. Zhejiang Huahai Pharmaceutical Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 175. Zhejiang Huahai Pharmaceutical Main Business

Table 176. Zhejiang Huahai Pharmaceutical Latest Developments

Table 177. Venkata Narayana Active Ingredients Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors

Table 178. Venkata Narayana Active Ingredients Olmesartan API Product Offered

Table 179. Venkata Narayana Active Ingredients Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 180. Venkata Narayana Active Ingredients Main Business

Table 181. Venkata Narayana Active Ingredients Latest Developments

Table 182. Cadila Pharmaceuticals Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors

Table 183. Cadila Pharmaceuticals Olmesartan API Product Offered

Table 184. Cadila Pharmaceuticals Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 185. Cadila Pharmaceuticals Main Business

Table 186. Cadila Pharmaceuticals Latest Developments

Table 187. Unimark Remedies Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors

Table 188. Unimark Remedies Olmesartan API Product Offered

Table 189. Unimark Remedies Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 190. Unimark Remedies Main Business

Table 191. Unimark Remedies Latest Developments

Table 192. Vasudha Pharma Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors

Table 193. Vasudha Pharma Olmesartan API Product Offered

Table 194. Vasudha Pharma Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 195. Vasudha Pharma Main Business

Table 196. Vasudha Pharma Latest Developments

Table 197. Macleods Pharmaceuticals Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors

Table 198. Macleods Pharmaceuticals Olmesartan API Product Offered

Table 199. Macleods Pharmaceuticals Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 200. Macleods Pharmaceuticals Main Business

Table 201. Macleods Pharmaceuticals Latest Developments

Table 202. Mylan Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors

Table 203. Mylan Olmesartan API Product Offered

Table 204. Mylan Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 205. Mylan Main Business

Table 206. Mylan Latest Developments

List of Figures

Figure 1. Picture of Olmesartan API

Figure 2. Olmesartan API Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Olmesartan API Sales Growth Rate 2017-2028 (Tons)

Figure 7. Global Olmesartan API Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Olmesartan API Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Purity 99%

Figure 10. Product Picture of Purity > 99%

Figure 11. Global Olmesartan API Sales Market Share by Type in 2021

Figure 12. Global Olmesartan API Revenue Market Share by Type (2017-2022)

Figure 13. Olmesartan API Consumed in Tablet Products

Figure 14. Global Olmesartan API Market: Tablet Products (2017-2022) & (Tons)

Figure 15. Olmesartan API Consumed in Capsule Products

Figure 16. Global Olmesartan API Market: Capsule Products (2017-2022) & (Tons)

Figure 17. Olmesartan API Consumed in Others

Figure 18. Global Olmesartan API Market: Others (2017-2022) & (Tons)

Figure 19. Global Olmesartan API Sales Market Share by Application (2017-2022)

Figure 20. Global Olmesartan API Revenue Market Share by Application in 2021

Figure 21. Olmesartan API Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Olmesartan API Revenue Market Share by Company in 2021

Figure 23. Global Olmesartan API Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Olmesartan API Revenue Market Share by Geographic Region in 2021

Figure 25. Global Olmesartan API Sales Market Share by Region (2017-2022)

Figure 26. Global Olmesartan API Revenue Market Share by Country/Region in 2021

Figure 27. Americas Olmesartan API Sales 2017-2022 (Tons)

Figure 28. Americas Olmesartan API Revenue 2017-2022 ($ Millions)

Figure 29. APAC Olmesartan API Sales 2017-2022 (Tons)

Figure 30. APAC Olmesartan API Revenue 2017-2022 ($ Millions)

Figure 31. Europe Olmesartan API Sales 2017-2022 (Tons)

Figure 32. Europe Olmesartan API Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Olmesartan API Sales 2017-2022 (Tons)

Figure 34. Middle East & Africa Olmesartan API Revenue 2017-2022 ($ Millions)

Figure 35. Americas Olmesartan API Sales Market Share by Country in 2021

Figure 36. Americas Olmesartan API Revenue Market Share by Country in 2021

Figure 37. United States Olmesartan API Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Olmesartan API Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Olmesartan API Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Olmesartan API Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Olmesartan API Sales Market Share by Region in 2021

Figure 42. APAC Olmesartan API Revenue Market Share by Regions in 2021

Figure 43. China Olmesartan API Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Olmesartan API Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Olmesartan API Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Olmesartan API Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Olmesartan API Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Olmesartan API Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Olmesartan API Sales Market Share by Country in 2021

Figure 50. Europe Olmesartan API Revenue Market Share by Country in 2021

Figure 51. Germany Olmesartan API Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Olmesartan API Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Olmesartan API Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Olmesartan API Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Olmesartan API Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Olmesartan API Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Olmesartan API Revenue Market Share by Country in 2021

Figure 58. Egypt Olmesartan API Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Olmesartan API Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Olmesartan API Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Olmesartan API Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Olmesartan API Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Olmesartan API in 2021

Figure 64. Manufacturing Process Analysis of Olmesartan API

Figure 65. Industry Chain Structure of Olmesartan API

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390